Interleukin-32 Gamma as a New Face in Inflammatory Bone Diseases
Journal of Rheumatic Diseases
;
: 14-20, 2017.
Artículo
en Inglés
| WPRIM
| ID: wpr-160555
ABSTRACT
Interleukin-32 (IL-32), a recently identified pro-inflammatory cytokine, is involved in the pathogenesis and progression of infections, cancer, chronic inflammation, and autoimmune disease. IL-32γ is the most active isoform in cell death and cell activation among nine distinct isoforms of IL-32. IL-32γ potentiates both osteogenic and osteoclastogenic capacities, and is critical in the coupling of bone resorption and bone formation for maintenance of bone homeostasis. IL-32γ is strongly associated with inflammatory bone disorders such as rheumatoid arthritis, ankylosing spondylitis, and osteoporosis. In this review, we summarize current research on the role of IL-32γ in inflammatory bone disorders, highlighting this cytokine as a novel target for prognostic marker and control of these diseases.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Osteogénesis
/
Osteoporosis
/
Artritis Reumatoide
/
Enfermedades Autoinmunes
/
Espondilitis Anquilosante
/
Enfermedades Óseas
/
Resorción Ósea
/
Muerte Celular
/
Isoformas de Proteínas
/
Homeostasis
Idioma:
Inglés
Revista:
Journal of Rheumatic Diseases
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS